EVI-1 EXPRESSION IN LEUKEMIC PATIENTS WITH REARRANGEMENTS OF THE 3Q25-Q28 CHROMOSOMAL REGION

被引:0
|
作者
FICHELSON, S
DREYFUS, F
BERGER, R
MELLE, J
BASTARD, C
MICLEA, JM
GISSELBRECHT, S
机构
[1] HOP ST LOUIS,MALAD SANG CLIN,F-75010 PARIS,FRANCE
[2] INST GENET MOLEC,INSERM,U301,GENET CELLULAIRE & MOLEC LEUCEMIES LAB,PARIS,FRANCE
[3] CTR REG TRANSFUS SANGUINE & GENET HUMAINE,BOIS GUILLAUME,FRANCE
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Evi-zinc-finger protein gene is normally not expressed in hematopoietic cells. However, high Evi-1 mRNA expression has been reported in mouse myeloblastic leukemias, due to transcriptional activation by proviral integration in either the Fim-3 or Evi-1 loci. The human Evi-1 gene is located on chromosome 3q24-q28. In this paper three examples are presented of human acute myelogenous leukemias presenting common characteristics: (i) high Evi-1 mRNA expression; (ii) chromosomal abnormalities t(3;3)(q21;q26) or inv(3;3)(q21-22;q26); and (iii) high platelet counts and dystrophic megakaryocytes. Thirty-four other patients with hematological malignancies, among which 11 had chromosomal rearrangements in the 3q24-q28 region did not exhibit such abnormalities. Of the 13 permanent hemopoietic cell lines tested, Evi-1 RNA expression was found in HEL and K-562 cell lines. Weak Evi-1 expression was also seen in fibroblasts and lung cells. This expression was affected neither in skin cells from a patient with a 3q27 constitutional translocation nor in a lung epithelioma cell line containing an excess of chromosome 3 long arm. Ectopic strong expression of Evi-1 in human leukemias could define an uncommon subclass of acute myelogenous leukemias with translocations involving the 3q25-28 chromosomal domain and abnormal megakaryopoiesis.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 50 条
  • [1] THE HUMAN EVI-1 GENE IS LOCATED ON CHROMOSOME 3Q24-Q28 BUT IS NOT REARRANGED IN 3 CASES OF ACUTE NONLYMPHOCYTIC LEUKEMIAS CONTAINING T(3-5)(Q25-Q34) TRANSLOCATIONS
    MORISHITA, K
    PARGANAS, E
    BARTHOLOMEW, C
    SACCHI, N
    VALENTINE, MB
    RAIMONDI, SC
    LEBEAU, MM
    IHLE, JN
    ONCOGENE RESEARCH, 1990, 5 (03) : 221 - 231
  • [2] Structurally altered Evi-1 protein generated in the 3q21q26 syndrome
    Ogawa, S
    Kurokawa, M
    Tanaka, T
    Mitani, K
    Inazawa, J
    Hangaishi, A
    Tanaka, K
    Matsuo, Y
    Minowada, J
    Tsubota, T
    Yazaki, Y
    Hirai, H
    ONCOGENE, 1996, 13 (01) : 183 - 191
  • [3] Structurally altered EVI-1 protein generated in the 3Q21Q26 syndrome.
    Ogawa, S
    Kurokawa, M
    Tanaka, T
    Mitani, K
    Inazawa, J
    Hangaishi, A
    Tanaka, K
    Matsuo, Y
    Minowada, J
    Tsubota, T
    Yazaki, Y
    Hirai, H
    BLOOD, 1996, 88 (10) : 2190 - 2190
  • [4] Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies
    Wieser, R
    Schreiner, U
    Rieder, H
    Pirc-Danoewinata, H
    Grüner, H
    Loncarevic, IF
    Fonatsch, C
    HAEMATOLOGICA, 2003, 88 (01) : 25 - 30
  • [5] COMPLEX CHROMOSOMAL REARRANGEMENTS LEADING TO EVI1 OVEREXPRESSION ARE RECURRENT MECHANISMS IN CASES WITH VARIOUS 3Q ABNORMALITIES
    Baldazzi, C.
    Ottaviani, E.
    Luatti, S.
    Marzocchi, G.
    Ameli, G.
    Papayannidis, C.
    Gamberini, C.
    Zuffa, E.
    Cavo, M.
    Martinelli, G.
    Testoni, N.
    HAEMATOLOGICA, 2014, 99 : 285 - 285
  • [6] Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26
    Schnittger, S
    deSauvage, FJ
    LePaslier, D
    Fonatsch, C
    LEUKEMIA, 1996, 10 (12) : 1891 - 1896
  • [7] GATA2 may contribute with EVI1 to the leukemogenic mechanism in patients with 3q21q26 rearrangements
    Vazquez, I
    Lahortiga, I
    Marcotegui, N
    Larrayoz, MJ
    Vicente, C
    Hernandez, JM
    Cervera, J
    Vidal, MJ
    Marquez, JA
    Calasanz, MJ
    Odero, MD
    BLOOD, 2005, 106 (11) : 799A - 800A
  • [8] DNA REARRANGEMENTS PROXIMAL TO THE EVI1 LOCUS ASSOCIATED WITH THE 3Q21Q26 SYNDROME
    LEVY, ER
    PARGANAS, E
    MORISHITA, K
    FICHELSON, S
    JAMES, L
    OSCIER, D
    GISSELBRECHT, S
    IHLE, JN
    BUCKLE, VJ
    BLOOD, 1994, 83 (05) : 1348 - 1354
  • [9] 3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review
    De Braekeleer, Marc
    Le Bris, Marie-Josee
    De Braekeleer, Etienne
    Basinko, Audrey
    Morel, Frederic
    Douet-Guilbert, Nathalie
    FUTURE ONCOLOGY, 2015, 11 (11) : 1675 - 1686
  • [10] Characterization of 3q26.2/EVI1 Rearrangements in Myelodysplastic/myeloproliferative Neoplasms
    Hu, Zhihong
    Hu, Shimin
    Wang, Xiaohong Iris
    Medeiros, L. Jeffrey
    Wang, Wei
    LABORATORY INVESTIGATION, 2018, 98 : 522 - 522